{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:58:45Z","timestamp":1792173525203,"version":"4.4.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00253-022-11989-w","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T10:03:21Z","timestamp":1654077801000},"page":"3957-3972","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Anti-bacterial monoclonal antibodies: next generation therapy against superbugs"],"prefix":"10.1007","volume":"106","author":[{"given":"Hui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daijie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8748-7899","authenticated-orcid":false,"given":"Huili","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"11989_CR1","doi-asserted-by":"publisher","unstructured":"Adamo R, Margarit I (2018) Fighting antibiotic-resistant Klebsiella pneumoniae with \"sweet\" immune targets. mBio 9(3):e00874\u201318. https:\/\/doi.org\/10.1128\/mBio.00874-18","DOI":"10.1128\/mBio.00874-18"},{"issue":"6","key":"11989_CR2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1080\/21505594.2016.1231295","volume":"8","author":"JL Aguilar","year":"2017","unstructured":"Aguilar JL, Varshney AK, Pechuan X, Dutta K, Nosanchuk JD, Fries BC (2017) Monoclonal antibodies protect from Staphylococcal Enterotoxin K (SEK) induced toxic shock and sepsis by USA300 Staphylococcus aureus. Virulence 8(6):741\u2013750. https:\/\/doi.org\/10.1080\/21505594.2016.1231295","journal-title":"Virulence"},{"issue":"1","key":"11989_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/jam.14471","volume":"128","author":"A Al-Sharqi","year":"2020","unstructured":"Al-Sharqi A, Apun K, Vincent M, Kanakaraju D, Bilung LM, Sum MSH (2020) Investigation of the antibacterial activity of Ag-NPs conjugated with a specific antibody against Staphylococcus aureus after photoactivation. J Appl Microbiol 128(1):102\u2013115. https:\/\/doi.org\/10.1111\/jam.14471","journal-title":"J Appl Microbiol"},{"issue":"3","key":"11989_CR4","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3892\/ijo.2016.3614","volume":"49","author":"M Altai","year":"2016","unstructured":"Altai M, Liu H, Orlova A, Tolmachev V, Graslund T (2016) Influence of molecular design on biodistribution and targeting properties of an Affibody-fused HER2-recognising anticancer toxin. Int J Oncol 49(3):1185\u20131194. https:\/\/doi.org\/10.3892\/ijo.2016.3614","journal-title":"Int J Oncol"},{"issue":"7","key":"11989_CR5","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1080\/19420862.2016.1215791","volume":"8","author":"A Badarau","year":"2016","unstructured":"Badarau A, Rouha H, Malafa S, Battles MB, Walker L, Nielson N, Dolezilkova I, Teubenbacher A, Banerjee S, Maierhofer B, Weber S, Stulik L, Logan DT, Welin M, Mirkina I, Pleban C, Zauner G, Gross K, Jagerhofer M, Magyarics Z, Nagy E (2016) Context matters: the importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies. MAbs 8(7):1347\u20131360. https:\/\/doi.org\/10.1080\/19420862.2016.1215791","journal-title":"MAbs"},{"issue":"5","key":"11989_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/toxins8050134","volume":"8","author":"S Di Bella","year":"2016","unstructured":"Di Bella S, Ascenzi P, Siarakas S, Petrosillo N, di Masi A (2016) Clostridium difficile Toxins A and B: insights into pathogenic properties and extraintestinal effects. Toxins (Basel) 8(5):134. https:\/\/doi.org\/10.3390\/toxins8050134","journal-title":"Toxins (Basel)"},{"issue":"5","key":"11989_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.nbt.2011.03.018","volume":"28","author":"JD Berry","year":"2011","unstructured":"Berry JD, Gaudet RG (2011) Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology. New Biotechnol 28(5):489\u2013501. https:\/\/doi.org\/10.1016\/j.nbt.2011.03.018","journal-title":"New Biotechnol"},{"issue":"4","key":"11989_CR8","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1128\/AAC.04593-14","volume":"59","author":"B Biron","year":"2015","unstructured":"Biron B, Beck K, Dyer D, Mattix M, Twenhafel N, Nalca A (2015) Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax. Antimicrob Agents Chemother 59(4):2206\u20132214. https:\/\/doi.org\/10.1128\/AAC.04593-14","journal-title":"Antimicrob Agents Chemother"},{"issue":"24","key":"11989_CR9","doi-asserted-by":"publisher","first-page":"6340","DOI":"10.1016\/j.bmc.2016.03.018","volume":"24","author":"TD Bugg","year":"2016","unstructured":"Bugg TD, Rodolis MT, Mihalyi A, Jamshidi S (2016) Inhibition of phospho-MurNAc-pentapeptide translocase (MraY) by nucleoside natural product antibiotics, bacteriophage varphiX174 lysis protein E, and cationic antibacterial peptides. Bioorg Med Chem 24(24):6340\u20136347. https:\/\/doi.org\/10.1016\/j.bmc.2016.03.018","journal-title":"Bioorg Med Chem"},{"issue":"9","key":"11989_CR10","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1080\/21645515.2017.1337613","volume":"13","author":"J Cao","year":"2017","unstructured":"Cao J, Yi F, Tian Q, Dang G, Si W, Liu S, Yu S (2017) Targeting the gram-negative bacteria peptidoglycan synthase MraY as a new approach for monoclonal antibody anti-bacterial activity. Hum Vaccines Immunotherapeutics 13(9):2086\u20132091. https:\/\/doi.org\/10.1080\/21645515.2017.1337613","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"7","key":"11989_CR11","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1128\/IAI.00078-07","volume":"75","author":"N Cerca","year":"2007","unstructured":"Cerca N, Jefferson KK, Maira-Litran T, Pier DB, Kelly-Quintos C, Goldmann DA, Azeredo J, Pier GB (2007) Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1\u20136)-glucosamine. Infect Immun 75(7):3406\u20133413. https:\/\/doi.org\/10.1128\/IAI.00078-07","journal-title":"Infect Immun"},{"issue":"2","key":"11989_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4140\/TCP.n.2018.89","volume":"33","author":"EB Chahine","year":"2018","unstructured":"Chahine EB, Cho JC, Worley MV (2018) Bezlotoxumab for the prevention of Clostridium difficile recurrence. Consult Pharm 33(2):89\u201397. https:\/\/doi.org\/10.4140\/TCP.n.2018.89","journal-title":"Consult Pharm"},{"issue":"12","key":"11989_CR13","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1016\/j.bbamem.2017.09.020","volume":"1859","author":"D Chaturvedi","year":"2017","unstructured":"Chaturvedi D, Mahalakshmi R (2017) Transmembrane beta-barrels: evolution, folding and energetics. Biochim Biophys Acta 1859(12):2467\u20132482. https:\/\/doi.org\/10.1016\/j.bbamem.2017.09.020","journal-title":"Biochim Biophys Acta"},{"issue":"37","key":"11989_CR14","doi-asserted-by":"publisher","first-page":"22992","DOI":"10.1073\/pnas.2003621117","volume":"117","author":"X Chen","year":"2020","unstructured":"Chen X, Shi M, Tong X, Kim HK, Wang LX, Schneewind O, Missiakas D (2020) Glycosylation-dependent opsonophagocytic activity of staphylococcal protein A antibodies. Proc Natl Acad Sci U S A 117(37):22992\u201323000. https:\/\/doi.org\/10.1073\/pnas.2003621117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11989_CR15","doi-asserted-by":"publisher","unstructured":"Chen X, Schneewind O, Missiakas D (2022) Engineered human antibodies for the opsonization and killing of Staphylococcus aureus. Proc Natl Acad Sci U S A\u00a0119(4):e2114478119. https:\/\/doi.org\/10.1073\/pnas.2114478119","DOI":"10.1073\/pnas.2114478119"},{"issue":"329","key":"11989_CR16","doi-asserted-by":"publisher","first-page":"329ra31","DOI":"10.1126\/scitranslmed.aad9922","volume":"8","author":"TS Cohen","year":"2016","unstructured":"Cohen TS, Hilliard JJ, Jones-Nelson O, Keller AE, O\u2019Day T, Tkaczyk C, DiGiandomenico A, Hamilton M, Pelletier M, Wang Q, Diep BA, Le VT, Cheng L, Suzich J, Stover CK, Sellman BR (2016) Staphylococcus aureus \u03b1 toxin potentiates opportunistic bacterial lung infections. Sci Transl Med 8(329):329ra31. https:\/\/doi.org\/10.1126\/scitranslmed.aad9922","journal-title":"Sci Transl Med"},{"key":"11989_CR17","doi-asserted-by":"publisher","first-page":"e67301","DOI":"10.7554\/eLife.67301","volume":"11","author":"L de Vor","year":"2022","unstructured":"de Vor L, van Dijk B, van Kessel K, Kavanaugh JS, de Haas C, Aerts PC, Viveen MC, Boel EC, Fluit AC, Kwiecinski JM, Krijger GC, Ramakers RM, Beekman FJ, Dadachova E, Lam MG, Vogely HC, van der Wal BC, van Strijp JA, Horswill AR, Weinans H, Rooijakkers SH (2022) Human monoclonal antibodies against Staphylococcus aureus surface antigens recognize in vitro and in vivo biofilm. Elife 11:e67301. https:\/\/doi.org\/10.7554\/eLife.67301","journal-title":"Elife"},{"issue":"6","key":"11989_CR18","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1080\/19420862.2019.1627152","volume":"11","author":"R Deng","year":"2019","unstructured":"Deng R, Zhou C, Li D, Cai H, Sukumaran S, Carrasco-Triguero M, Saad O, Nazzal D, Lowe C, Ramanujan S, Kamath AV (2019) Preclinical and translational pharmacokinetics of a novel THIOMAB\u2122 antibody-antibiotic conjugate against Staphylococcus aureus. MAbs 11(6):1162\u20131174. https:\/\/doi.org\/10.1080\/19420862.2019.1627152","journal-title":"MAbs"},{"key":"11989_CR19","doi-asserted-by":"publisher","unstructured":"Diago-Navarro E, Calatayud-Baselga I, Sun D, Khairallah C, Mann I, Ulacia-Hernando A, Sheridan B, Shi M, Fries BC (2017) Antibody-based immunotherapy to treat and prevent infection with hypervirulent Klebsiella pneumoniae. Clin Vaccine Immunol 24(1):e00456\u201316. https:\/\/doi.org\/10.1128\/cvi.00456-16","DOI":"10.1128\/cvi.00456-16"},{"key":"11989_CR20","doi-asserted-by":"publisher","unstructured":"Diago-Navarro E, Motley MP, Ruiz-Per\u00e9z G, Yu W, Austin J, Seco BMS, Xiao G, Chikhalya A, Seeberger PH, Fries BC (2018) Novel, broadly reactive anticapsular antibodies against carbapenem-resistant Klebsiella pneumoniae protect from infection. mBio 9(2):e00091\u201318. https:\/\/doi.org\/10.1128\/mBio.00091-18","DOI":"10.1128\/mBio.00091-18"},{"issue":"262","key":"11989_CR21","doi-asserted-by":"publisher","first-page":"262ra155","DOI":"10.1126\/scitranslmed.3009655","volume":"6","author":"A DiGiandomenico","year":"2014","unstructured":"DiGiandomenico A, Keller AE, Gao C, Rainey GJ, Warrener P, Camara MM, Bonnell J, Fleming R, Bezabeh B, Dimasi N, Sellman BR, Hilliard J, Guenther CM, Datta V, Zhao W, Gao C, Yu XQ, Suzich JA, Stover CK (2014) A multifunctional bispecific antibody protects against Pseudomonas aeruginosa. Sci Transl Med 6(262):262ra155. https:\/\/doi.org\/10.1126\/scitranslmed.3009655","journal-title":"Sci Transl Med"},{"issue":"1","key":"11989_CR22","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1038\/s41467-019-11230-9","volume":"10","author":"MT Doyle","year":"2019","unstructured":"Doyle MT, Bernstein HD (2019) Bacterial outer membrane proteins assemble via asymmetric interactions with the BamA beta-barrel. Nat Commun 10(1):3358. https:\/\/doi.org\/10.1038\/s41467-019-11230-9","journal-title":"Nat Commun"},{"issue":"9","key":"11989_CR23","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/s1473-3099(20)30995-6","volume":"21","author":"B Fran\u00e7ois","year":"2021","unstructured":"Fran\u00e7ois B, Jafri HS, Chastre J, S\u00e1nchez-Garc\u00eda M, Eggimann P, Dequin PF, Huberlant V, Vi\u00f1a Soria L, Boulain T, Bretonni\u00e8re C, Pugin J, Trenado J, Hernandez Padilla AC, Ali O, Shoemaker K, Ren P, Coenjaerts FE, Ruzin A, Barraud O, Timbermont L, Lammens C, Pierre V, Wu Y, Vignaud J, Colbert S, Bellamy T, Esser MT, Dubovsky F, Bonten MJ, Goossens H, Laterre PF (2021) Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial. Lancet Infect Dis 21(9):1313\u20131323. https:\/\/doi.org\/10.1016\/s1473-3099(20)30995-6","journal-title":"Lancet Infect Dis"},{"key":"11989_CR24","doi-asserted-by":"publisher","unstructured":"Francois B, Sanchez MG, Eggimann P, Dequin P, Laterre P, Huberlant V, Escudero D, Boulain T, Bretonniere C, Pugin J, Alvarez JT, Ali O, Shoemaker K, Ruzin A, Vandamme D, Colbert S, Bellamy T, Dubovsky F, Jafri H, Grp SS (2019) Suvratoxumab reduces Staphylococcus aureus pneumonia in high-risk ICU patients: results of the SAATELLITE study. Am J Respir Crit Care Med 199:A7358. https:\/\/doi.org\/10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A7358","DOI":"10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A7358"},{"key":"11989_CR25","doi-asserted-by":"publisher","first-page":"104240","DOI":"10.1016\/j.micpath.2020.104240","volume":"145","author":"F Gao","year":"2020","unstructured":"Gao F, Zhai G, Wang H, Lu L, Xu J, Zhu J, Chen D, Lu H (2020) Protective effects of anti-alginate monoclonal antibody against Pseudomonas aeruginosa infection of HeLa cells. Microb Pathog 145:104240. https:\/\/doi.org\/10.1016\/j.micpath.2020.104240","journal-title":"Microb Pathog"},{"issue":"2","key":"11989_CR26","doi-asserted-by":"publisher","first-page":"e01590","DOI":"10.1128\/AAC.01590-17","volume":"62","author":"LN Henning","year":"2018","unstructured":"Henning LN, Carpenter S, Stark GV, Serbina NV (2018) Development of protective immunity in New Zealand white rabbits challenged with Bacillus anthracis spores and treated with antibiotics and obiltoxaximab, a monoclonal antibody against protective antigen. Antimicrob Agents Chemother 62(2):e01590-e1617. https:\/\/doi.org\/10.1128\/AAC.01590-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"11989_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1089\/mab.2019.0028","volume":"38","author":"R Hnasko","year":"2019","unstructured":"Hnasko R, Lin AV, McGarvey JA (2019) Rapid detection of Staphylococcal Enterotoxin-B by lateral flow assay. Monoclon Antib Immunodiagn Immunother 38(5):209\u2013212. https:\/\/doi.org\/10.1089\/mab.2019.0028","journal-title":"Monoclon Antib Immunodiagn Immunother"},{"issue":"Pt 9","key":"11989_CR28","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1107\/s2059798321007816","volume":"77","author":"F Hoelzgen","year":"2021","unstructured":"Hoelzgen F, Zalk R, Alcalay R, Cohen-Schwartz S, Garau G, Shahar A, Mazor O, Frank GA (2021) Neutralization of the anthrax toxin by antibody-mediated stapling of its membrane-penetrating loop. Acta Crystallographica Section d, Structural Biology 77(Pt 9):1197\u20131205. https:\/\/doi.org\/10.1107\/s2059798321007816","journal-title":"Acta Crystallographica Section d, Structural Biology"},{"key":"11989_CR29","doi-asserted-by":"publisher","first-page":"126719","DOI":"10.1016\/j.micres.2021.126719","volume":"246","author":"G Horna","year":"2021","unstructured":"Horna G, Ruiz J (2021) Type 3 secretion system of Pseudomonas aeruginosa. Microbiol Res 246:126719. https:\/\/doi.org\/10.1016\/j.micres.2021.126719","journal-title":"Microbiol Res"},{"issue":"2","key":"11989_CR30","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1128\/aac.02190-13","volume":"58","author":"L Hua","year":"2014","unstructured":"Hua L, Hilliard JJ, Shi Y, Tkaczyk C, Cheng LI, Yu X, Datta V, Ren S, Feng H, Zinsou R, Keller A, O\u2019Day T, Du Q, Cheng L, Damschroder M, Robbie G, Suzich J, Stover CK, Sellman BR (2014) Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia. Antimicrob Agents Chemother 58(2):1108\u20131117. https:\/\/doi.org\/10.1128\/aac.02190-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"11989_CR31","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.1128\/AAC.00510-15","volume":"59","author":"L Hua","year":"2015","unstructured":"Hua L, Cohen TS, Shi Y, Datta V, Hilliard JJ, Tkaczyk C, Suzich J, Stover CK, Sellman BR (2015) MEDI4893* Promotes survival and extends the antibiotic treatment window in a Staphylococcus aureus immunocompromised pneumonia model. Antimicrob Agents Chemother 59(8):4526\u20134532. https:\/\/doi.org\/10.1128\/AAC.00510-15","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"11989_CR32","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.3390\/toxins7103960","volume":"7","author":"B Huang","year":"2015","unstructured":"Huang B, Xie T, Rotstein D, Fang H, Frucht DM (2015) Passive immunotherapy protects against enteric invasion and lethal sepsis in a murine model of gastrointestinal anthrax. Toxins (basel) 7(10):3960\u20133976. https:\/\/doi.org\/10.3390\/toxins7103960","journal-title":"Toxins (basel)"},{"issue":"32","key":"11989_CR33","doi-asserted-by":"publisher","first-page":"35918","DOI":"10.1021\/acsami.0c09364","volume":"12","author":"K Ivanova","year":"2020","unstructured":"Ivanova K, Ivanova A, Ramon E, Hoyo J, Sanchez-Gomez S, Tzanov T (2020) Antibody-enabled antimicrobial nanocapsules for selective elimination of Staphylococcus aureus. ACS Appl Mater Interfaces 12(32):35918\u201335927. https:\/\/doi.org\/10.1021\/acsami.0c09364","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"11989_CR34","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jcf.2017.12.006","volume":"17","author":"R Jain","year":"2018","unstructured":"Jain R, Beckett VV, Konstan MW, Accurso FJ, Burns JL, Mayer-Hamblett N, Milla C, VanDevanter DR, Chmiel JF, Group KAS (2018) KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa. J Cyst Fibros: Off J Eur Cys Fibros Soc 17(4):484\u2013491. https:\/\/doi.org\/10.1016\/j.jcf.2017.12.006","journal-title":"J Cyst Fibros: Off J Eur Cys Fibros Soc"},{"issue":"3","key":"11989_CR35","doi-asserted-by":"publisher","first-page":"e0020221","DOI":"10.1128\/mBio.00202-21","volume":"12","author":"KK Kajihara","year":"2021","unstructured":"Kajihara KK, Pantua H, Hernandez-Barry H, Hazen M, Deshmukh K, Chiang N, Ohri R, Castellanos ER, Martin L, Matsumoto ML, Payandeh J, Storek KM, Schneider K, Smith PA, Koehler MFT, Tsai SP, Vandlen R, Loyet KM, Nakamura G, Pillow T, Seshasayee D, Kapadia SB, Hazenbos WLW (2021) Potent killing of Pseudomonas aeruginosa by an antibody-antibiotic conjugate. mBio 12(3):e0020221. https:\/\/doi.org\/10.1128\/mBio.00202-21","journal-title":"mBio"},{"issue":"2","key":"11989_CR36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2174\/1389450117666161128123536","volume":"19","author":"TL Kane","year":"2018","unstructured":"Kane TL, Carothers KE, Lee SW (2018) Virulence factor targeting of the bacterial pathogen Staphylococcus aureus for vaccine and therapeutics. Curr Drug Targets 19(2):111\u2013127. https:\/\/doi.org\/10.2174\/1389450117666161128123536","journal-title":"Curr Drug Targets"},{"issue":"7","key":"11989_CR37","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1080\/21505594.2016.1267894","volume":"8","author":"MJ Karau","year":"2017","unstructured":"Karau MJ, Tilahun ME, Krogman A, Osborne BA, Goldsby RA, David CS, Mandrekar JN, Patel R, Rajagopalan G (2017) Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus. Virulence 8(7):1148\u20131159. https:\/\/doi.org\/10.1080\/21505594.2016.1267894","journal-title":"Virulence"},{"key":"11989_CR38","doi-asserted-by":"publisher","unstructured":"Kaufmann SH (2017) Remembering Emil von Behring: from tetanus treatment to antibody cooperation with phagocytes. mBio 8(1):e00117\u201317. https:\/\/doi.org\/10.1128\/mBio.00117-17","DOI":"10.1128\/mBio.00117-17"},{"issue":"5","key":"11989_CR39","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1128\/IAI.74.5.2742-2750.2006","volume":"74","author":"C Kelly-Quintos","year":"2006","unstructured":"Kelly-Quintos C, Cavacini LA, Posner MR, Goldmann D, Pier GB (2006) Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine. Infect Immun 74(5):2742\u20132750. https:\/\/doi.org\/10.1128\/IAI.74.5.2742-2750.2006","journal-title":"Infect Immun"},{"issue":"10","key":"11989_CR40","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1128\/IAI.00230-12","volume":"80","author":"HK Kim","year":"2012","unstructured":"Kim HK, Emolo C, DeDent AC, Falugi F, Missiakas DM, Schneewind O (2012) Protein A-specific monoclonal antibodies and prevention of Staphylococcus aureus disease in mice. Infect Immun 80(10):3460\u20133470. https:\/\/doi.org\/10.1128\/IAI.00230-12","journal-title":"Infect Immun"},{"key":"11989_CR41","doi-asserted-by":"publisher","unstructured":"Kobayashi SD, Porter AR, Freedman B, Pandey R, Chen L, Kreiswirth BN, Deleo FR (2018) Antibody-mediated killing of carbapenem-resistant ST258 Klebsiella pneumoniae by human neutrophils. Mbio 9(2):e00297\u201318. https:\/\/doi.org\/10.1128\/mBio.00297-18","DOI":"10.1128\/mBio.00297-18"},{"issue":"10","key":"11989_CR42","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/phar.1990","volume":"37","author":"WD Kufel","year":"2017","unstructured":"Kufel WD, Devanathan AS, Marx AH, Weber DJ, Daniels LM (2017) Bezlotoxumab: a novel agent for the prevention of recurrent Clostridium difficile infection. Pharmacotherapy 37(10):1298\u20131308. https:\/\/doi.org\/10.1002\/phar.1990","journal-title":"Pharmacotherapy"},{"issue":"9","key":"11989_CR43","doi-asserted-by":"publisher","first-page":"6222","DOI":"10.4049\/jimmunol.180.9.6222","volume":"180","author":"TJ LaRocca","year":"2008","unstructured":"LaRocca TJ, Katona LI, Thanassi DG, Benach JL (2008) Bactericidal action of a complement-independent antibody against relapsing fever Borrelia resides in its variable region. J Immunol 180(9):6222\u20136228. https:\/\/doi.org\/10.4049\/jimmunol.180.9.6222","journal-title":"J Immunol"},{"issue":"26","key":"11989_CR44","doi-asserted-by":"publisher","first-page":"10752","DOI":"10.1073\/pnas.0901858106","volume":"106","author":"TJ LaRocca","year":"2009","unstructured":"LaRocca TJ, Holthausen DJ, Hsieh C, Renken C, Mannella CA, Benach JL (2009) The bactericidal effect of a complement-independent antibody is osmolytic and specific to Borrelia. Proc Natl Acad Sci U S A 106(26):10752\u201310757. https:\/\/doi.org\/10.1073\/pnas.0901858106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"11989_CR45","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1021\/acs.biomac.1c00082","volume":"22","author":"H Le","year":"2021","unstructured":"Le H, Arnoult C, D\u00e9 E, Schapman D, Galas L, Le Cerf D, Karakasyan C (2021) Antibody-conjugated nanocarriers for targeted antibiotic delivery: application in the treatment of bacterial biofilms. Biomacromol 22(4):1639\u20131653. https:\/\/doi.org\/10.1021\/acs.biomac.1c00082","journal-title":"Biomacromol"},{"key":"11989_CR46","doi-asserted-by":"publisher","unstructured":"Le HN, Quetz JS, Tran VG, Le VTM, Aguiar-Alves F, Pinheiro MG, Cheng L, Yu L, Sellman BR, Stover CK, DiGiandomenico A, Diep BA (2018) MEDI3902 correlates of protection against severe Pseudomonas aeruginosa pneumonia in a rabbit acute pneumonia model. Antimicrob Agents Chemother 62(5):e02565\u201317. https:\/\/doi.org\/10.1128\/aac.02565-17","DOI":"10.1128\/aac.02565-17"},{"issue":"7578","key":"11989_CR47","doi-asserted-by":"publisher","first-page":"323-+","DOI":"10.1038\/nature16057","volume":"527","author":"SM Lehar","year":"2015","unstructured":"Lehar SM, Pillow T, Xu M, Staben L, Kajihara KK, Andlen RV, DePalatis L, Raab H, Hazenbos WL, Morisaki JH, Kim J, Park S, Darwish M, Lee B-C, Hernandez H, Loyet KM, Lupardus P, Fong R, Yan D, Halouni CC, Luis E, Khalfin Y, Plise E, Heong JC, Lyssikatos JP, Strandh M, Koefoed K, Andersen PS, Flygare JA, Tan MW, Brown EJ, Ariathasan SM (2015) Novel antibody-antibiotic conjugate eliminates intracellular S aureus. Nature 527(7578):323-+. https:\/\/doi.org\/10.1038\/nature16057","journal-title":"Nature"},{"issue":"3","key":"11989_CR48","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jmb.2009.02.003","volume":"387","author":"CE Leysath","year":"2009","unstructured":"Leysath CE, Monzingo AF, Maynard JA, Barnett J, Georgiou G, Iverson BL, Robertus JD (2009) Crystal structure of the engineered neutralizing antibody M18 complexed to domain 4 of the anthrax protective antigen. J Mol Biol 387(3):680\u2013693. https:\/\/doi.org\/10.1016\/j.jmb.2009.02.003","journal-title":"J Mol Biol"},{"issue":"5","key":"11989_CR49","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1517\/14712598.3.5.843","volume":"3","author":"S Liu","year":"2003","unstructured":"Liu S, Schubert RL, Bugge TH, Leppla SH (2003) Anthrax toxin: structures, functions and tumour targeting. Expert Opin Biol Ther 3(5):843\u2013853. https:\/\/doi.org\/10.1517\/14712598.3.5.843","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"11989_CR50","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/21505594.2017.1292199","volume":"8","author":"M Luciani","year":"2017","unstructured":"Luciani M, Lannetti L (2017) Monoclonal antibodies and bacterial virulence. Virulence 8(6):635\u2013636. https:\/\/doi.org\/10.1080\/21505594.2017.1292199","journal-title":"Virulence"},{"issue":"2","key":"11989_CR51","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.molmed.2016.12.008","volume":"23","author":"S Mariathasan","year":"2017","unstructured":"Mariathasan S, Tan MW (2017) Antibody-antibiotic conjugates: a novel therapeutic platform against bacterial infections. Trends Mol Med 23(2):135\u2013149. https:\/\/doi.org\/10.1016\/j.molmed.2016.12.008","journal-title":"Trends Mol Med"},{"issue":"6","key":"11989_CR52","doi-asserted-by":"publisher","first-page":"531","DOI":"10.4161\/mabs.1.6.10195","volume":"1","author":"S Mazumdar","year":"2009","unstructured":"Mazumdar S (2009) Raxibacumab. Mabs 1(6):531\u2013538. https:\/\/doi.org\/10.4161\/mabs.1.6.10195","journal-title":"Mabs"},{"issue":"5","key":"11989_CR53","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.drudis.2019.03.002","volume":"24","author":"MJ McConnell","year":"2019","unstructured":"McConnell MJ (2019) Where are we with monoclonal antibodies for multidrug-resistant infections? Drug Discov Today 24(5):1132\u20131138. https:\/\/doi.org\/10.1016\/j.drudis.2019.03.002","journal-title":"Drug Discov Today"},{"issue":"2","key":"11989_CR54","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1056\/NEJMoa0810603","volume":"361","author":"T-S Migone","year":"2009","unstructured":"Migone T-S, Subramanian GM, Zhong J, Healey LM, Corey A, Devalaraja M, Lo L, Ullrich S, Zimmerman J, Chen A, Lewis M, Meister G, Gillum K, Sanford D, Mott J, Bolmer SD (2009) Raxibacumab for the treatment of inhalational anthrax. N Engl J Med 361(2):135\u2013144. https:\/\/doi.org\/10.1056\/NEJMoa0810603","journal-title":"N Engl J Med"},{"issue":"7","key":"11989_CR55","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/ppul.22890","volume":"49","author":"CE Milla","year":"2014","unstructured":"Milla CE, Chmiel JF, Accurso FJ, VanDevanter DR, Konstan MW, Yarranton G, Geller DE, Group KBS (2014) Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection. Pediatr Pulmonol 49(7):650\u20138. https:\/\/doi.org\/10.1002\/ppul.22890","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"11989_CR56","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1462-5822.2011.01704.x","volume":"14","author":"M Mishra","year":"2012","unstructured":"Mishra M, Byrd MS, Sergeant S, Azad AK, Parsek MR, McPhail L, Schlesinger LS, Wozniak DJ (2012) Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization. Cell Microbiol 14(1):95\u2013106. https:\/\/doi.org\/10.1111\/j.1462-5822.2011.01704.x","journal-title":"Cell Microbiol"},{"key":"11989_CR57","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-micro-091014-104523","volume":"69","author":"M Moayeri","year":"2015","unstructured":"Moayeri M, Leppla SH, Vrentas C, Pomerantsev AP, Liu S (2015) Anthrax pathogenesis. Annu Rev Microbiol 69:185\u2013208. https:\/\/doi.org\/10.1146\/annurev-micro-091014-104523","journal-title":"Annu Rev Microbiol"},{"key":"11989_CR58","doi-asserted-by":"publisher","unstructured":"Motley M, Kasturi B, C FB (2019) Monoclonal antibody-based therapies for bacterial infections. Curr Opin Infect Dis 32(3):210\u2013216. https:\/\/doi.org\/10.1097\/QCO.0000000000000539","DOI":"10.1097\/QCO.0000000000000539"},{"key":"11989_CR59","doi-asserted-by":"publisher","unstructured":"Motley MP, Diago-Navarro E, Banerjee K, Inzerillo S, Fries BC (2020) The role of IgG subclass in antibody-mediated protection against carbapenem-resistant Klebsiella pneumoniae. mBio 11(5):e02059\u201320. https:\/\/doi.org\/10.1128\/mBio.02059-20","DOI":"10.1128\/mBio.02059-20"},{"issue":"9","key":"11989_CR60","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/j.clinthera.2016.07.170","volume":"38","author":"CF Nagy","year":"2016","unstructured":"Nagy CF, Leach TS, Hoffman JH, Czech A, Carpenter SE, Guttendorf R (2016) Pharmacokinetics and tolerability of obiltoxaximab: a report of 5 healthy volunteer studies. Clin Ther 38(9):2083-2097.e7. https:\/\/doi.org\/10.1016\/j.clinthera.2016.07.170","journal-title":"Clin Ther"},{"key":"11989_CR61","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-3-319-72077-7_7","volume":"1053","author":"E Nagy","year":"2017","unstructured":"Nagy E, Nagy G, Power CA, Badarau A, Szijarto V (2017) Anti-bacterial monoclonal antibodies. Adv Exp Med Biol 1053:119\u2013153. https:\/\/doi.org\/10.1007\/978-3-319-72077-7_7","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"11989_CR62","doi-asserted-by":"publisher","first-page":"10329","DOI":"10.1096\/fj.201902795R","volume":"34","author":"EN Natali","year":"2020","unstructured":"Natali EN, Principato S, Ferlicca F, Bianchi F, Fontana LE, Faleri A, Pansegrau W, Surdo PL, Bartolini E, Santini L, Brunelli B, Giusti F, Veggi D, Ferlenghi I, Norais N, Scarselli M (2020) Synergic complement-mediated bactericidal activity of monoclonal antibodies with distinct specificity. FASEB J: Off Publ Fed Am Soc Exp Biol 34(8):10329\u201310341. https:\/\/doi.org\/10.1096\/fj.201902795R","journal-title":"FASEB J: Off Publ Fed Am Soc Exp Biol"},{"key":"11989_CR63","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/BTT.S127099","volume":"12","author":"BD Navalkele","year":"2018","unstructured":"Navalkele BD, Chopra T (2018) Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection. Biologics 12:11\u201321. https:\/\/doi.org\/10.2147\/BTT.S127099","journal-title":"Biologics"},{"issue":"43","key":"11989_CR64","doi-asserted-by":"publisher","first-page":"29874","DOI":"10.1074\/jbc.M114.601328","volume":"289","author":"V Oganesyan","year":"2014","unstructured":"Oganesyan V, Peng L, Damschroder MM, Cheng L, Sadowska A, Tkaczyk C, Sellman BR, Wu H, Dall\u2019Acqua WF (2014) Mechanisms of neutralization of a human anti-alpha-toxin antibody. J Biol Chem 289(43):29874\u201329880. https:\/\/doi.org\/10.1074\/jbc.M114.601328","journal-title":"J Biol Chem"},{"issue":"26","key":"11989_CR65","doi-asserted-by":"publisher","first-page":"18008","DOI":"10.1074\/jbc.M114.560748","volume":"289","author":"P Orth","year":"2014","unstructured":"Orth P, Xiao L, Hernandez LD, Reichert P, Sheth PR, Beaumont M, Yang X, Murgolo N, Ermakov G, DiNunzio E, Racine F, Karczewski J, Secore S, Ingram RN, Mayhood T, Strickland C, Therien AG (2014) Mechanism of action and epitopes of Clostridium difficile toxin B-neutralizing antibody bezlotoxumab revealed by X-ray crystallography. J Biol Chem 289(26):18008\u201318021. https:\/\/doi.org\/10.1074\/jbc.M114.560748","journal-title":"J Biol Chem"},{"key":"11989_CR66","doi-asserted-by":"publisher","unstructured":"Ortines RV, Liu H, Cheng LI, Cohen TS, Lawlor H, Gami A, Wang Y, Dillen CA, Archer NK, Miller RJ, Ashbaugh AG, Pinsker BL, Marchitto MC, Tkaczyk C, Stover CK, Sellman BR, Miller LS (2018) Neutralizing alpha-toxin accelerates healing of Staphylococcus aureus-infected wounds in nondiabetic and diabetic mice. Antimicrob Agents Chemother 62(3):e02288\u201317. https:\/\/doi.org\/10.1128\/AAC.02288-17","DOI":"10.1128\/AAC.02288-17"},{"issue":"5","key":"11989_CR67","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1586\/14760584.2015.1001750","volume":"14","author":"M Patel","year":"2015","unstructured":"Patel M, Zipursky S, Orenstein W, Garon J, Zaffran M (2015) Polio endgame: the global introduction of inactivated polio vaccine. Expert Rev Vaccines 14(5):749\u2013762. https:\/\/doi.org\/10.1586\/14760584.2015.1001750","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"11989_CR68","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41467-017-00576-7","volume":"8","author":"A Patel","year":"2017","unstructured":"Patel A, DiGiandomenico A, Keller AE, Smith TRF, Park DH, Ramos S, Schultheis K, Elliott STC, Mendoza J, Broderick KE, Wise MC, Yan J, Jiang J, Flingai S, Khan AS, Muthumani K, Humeau L, Cheng LI, Wachter-Rosati L, Stover CK, Sardesai NY, Weiner DB (2017) An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model. Nat Commun 8(1):637. https:\/\/doi.org\/10.1038\/s41467-017-00576-7","journal-title":"Nat Commun"},{"issue":"1","key":"11989_CR69","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1038\/s41467-017-02223-7","volume":"8","author":"ME Pennini","year":"2017","unstructured":"Pennini ME, De Marco A, Pelletier M, Bonnell J, Cvitkovic R, Beltramello M, Cameroni E, Bianchi S, Zatta F, Zhao W, Xiao X, Camara MM, DiGiandomenico A, Semenova E, Lanzavecchia A, Warrener P, Suzich J, Wang Q, Corti D, Stover CK (2017) Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae. Nat Commun 8(1):1991. https:\/\/doi.org\/10.1038\/s41467-017-02223-7","journal-title":"Nat Commun"},{"issue":"9","key":"11989_CR70","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.4049\/jimmunol.173.9.5671","volume":"173","author":"GB Pier","year":"2004","unstructured":"Pier GB, Boyer D, Preston M, Coleman FT, Llosa N, Mueschenborn-Koglin S, Theilacker C, Goldenberg H, Uchin J, Priebe GP, Grout M, Posner M, Cavacini L (2004) Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. J Immunol (Baltimore, Md\u202f: 1950) 173(9):5671\u20138. https:\/\/doi.org\/10.4049\/jimmunol.173.9.5671","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"issue":"4","key":"11989_CR71","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1128\/IAI.01403-13","volume":"82","author":"KL Pinkston","year":"2014","unstructured":"Pinkston KL, Singh KV, Gao P, Wilganowski N, Robinson H, Ghosh S, Azhdarinia A, Sevick-Muraca EM, Murray BE, Harvey BR (2014) Targeting pili in enterococcal pathogenesis. Infect Immun 82(4):1540\u20131547. https:\/\/doi.org\/10.1128\/IAI.01403-13","journal-title":"Infect Immun"},{"issue":"3","key":"11989_CR72","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/infdis\/jis192","volume":"206","author":"ME Powers","year":"2012","unstructured":"Powers ME, Kim HK, Wang Y, Wardenburg JB (2012) ADAM10 mediates vascular injury induced by Staphylococcus aureus alpha-hemolysin. J Infect Dis 206(3):352\u2013356. https:\/\/doi.org\/10.1093\/infdis\/jis192","journal-title":"J Infect Dis"},{"issue":"4","key":"11989_CR73","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1128\/cmr.00048-09","volume":"23","author":"S Ram","year":"2010","unstructured":"Ram S, Lewis LA, Rice PA (2010) Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev 23(4):740\u2013780. https:\/\/doi.org\/10.1128\/cmr.00048-09","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"11989_CR74","doi-asserted-by":"publisher","first-page":"16065","DOI":"10.1038\/s41598-017-16215-6","volume":"7","author":"VA Ray","year":"2017","unstructured":"Ray VA, Hill PJ, Stover CK, Roy S, Sen CK, Yu L, Wozniak DJ, DiGiandomenico A (2017) Anti-Psl targeting of Pseudomonas aeruginosa biofilms for neutrophil-mediated disruption. Sci Rep 7(1):16065. https:\/\/doi.org\/10.1038\/s41598-017-16215-6","journal-title":"Sci Rep"},{"issue":"7","key":"11989_CR75","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/17512433.2019.1619454","volume":"12","author":"J Rello","year":"2019","unstructured":"Rello J, Parisella FR, Perez A (2019) Alternatives to antibiotics in an era of difficult-to-treat resistance: new insights. Expert Rev Clin Pharmacol 12(7):635\u2013642. https:\/\/doi.org\/10.1080\/17512433.2019.1619454","journal-title":"Expert Rev Clin Pharmacol"},{"key":"11989_CR76","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/82_2016_16","volume":"409","author":"T Reyes-Robles","year":"2017","unstructured":"Reyes-Robles T, Torres VJ (2017) Staphylococcus aureus pore-forming toxins. Curr Top Microbiol Immunol 409:121\u2013144. https:\/\/doi.org\/10.1007\/82_2016_16","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"11989_CR77","doi-asserted-by":"publisher","first-page":"243","DOI":"10.4161\/19420862.2014.985132","volume":"7","author":"H Rouha","year":"2015","unstructured":"Rouha H, Badarau A, Visram ZC, Battles MB, Prinz B, Magyarics Z, Nagy G, Mirkina I, Stulik L, Zerbs M, Jaegerhofer M, Maierhofer B, Teubenbacher A, Dolezilkova I, Gross K, Banerjee S, Zauner G, Malafa S, Zmajkovic J, Maier S, Mabry R, Krauland E, Wittrup KD, Gerngross TU, Nagy E (2015) Five birds, one stone: neutralization of alpha-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody. MAbs 7(1):243\u2013254. https:\/\/doi.org\/10.4161\/19420862.2014.985132","journal-title":"MAbs"},{"issue":"12","key":"11989_CR78","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1093\/jac\/dks335","volume":"67","author":"D Roux","year":"2012","unstructured":"Roux D, Pier GB, Skurnik D (2012) Magic bullets for the 21st century: the reemergence of immunotherapy for multi- and pan-resistant microbes. J Antimicrob Chemother 67(12):2785\u20132787. https:\/\/doi.org\/10.1093\/jac\/dks335","journal-title":"J Antimicrob Chemother"},{"key":"11989_CR79","doi-asserted-by":"publisher","unstructured":"Rukkawattanakul T, Sookrung N, Seesuay W, Onlamoon N, Diraphat P, Chaicumpa W, Indrawattana N (2017) Human scFvs that counteract bioactivities of Staphylococcus aureus TSST-1. Toxins (Basel) 9(2):50. https:\/\/doi.org\/10.3390\/toxins9020050","DOI":"10.3390\/toxins9020050"},{"key":"11989_CR80","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.3389\/fimmu.2018.02674","volume":"9","author":"M Sadarangani","year":"2018","unstructured":"Sadarangani M (2018) Protection against invasive infections in children caused by encapsulated bacteria. Front Immunol 9:2674. https:\/\/doi.org\/10.3389\/fimmu.2018.02674","journal-title":"Front Immunol"},{"issue":"1","key":"11989_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijantimicag.2018.02.012","volume":"52","author":"K Saeed","year":"2018","unstructured":"Saeed K, Esposito S, Gould I, Ascione T, Bassetti M, Bonnet E, Bouza E, Chan M, Davis JS, De Simone G, Dryden M, Gottlieb T, Hijazi K, Lye DC, Pagliano P, Petridou C, Righi E, Segreti J, Unal S, Yalcin AN (2018) Hot topics in necrotising skin and soft tissue infections. Int J Antimicrob Agents 52(1):1\u201310. https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.02.012","journal-title":"Int J Antimicrob Agents"},{"key":"11989_CR82","doi-asserted-by":"publisher","unstructured":"Satlin MJ, Chen L, Patel G, Gomez-Simmonds A, Weston G, Kim AC, Seo SK, Rosenthal ME, Sperber SJ, Jenkins SG, Hamula CL, Uhlemann AC, Levi MH, Fries BC, Tang YW, Juretschko S, Rojtman AD, Hong T, Mathema B, Jacobs MR, Walsh TJ, Bonomo RA, Kreiswirth BN (2017) Multicenter clinical and molecular epidemiological analysis of bacteremia due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE epicenter of the United States. Antimicrob Agents Chemother 61(4):e02349-16. https:\/\/doi.org\/10.1128\/AAC.02349-16","DOI":"10.1128\/AAC.02349-16"},{"key":"11989_CR83","doi-asserted-by":"publisher","unstructured":"Schiller ZA, Rudolph MJ, Toomey JR, Ejemel M, LaRochelle A, Davis SA, Lambert HS, Kern A, Tardo AC, Souders CA, Peterson E, Cannon RD, Ganesa C, Fazio F, Mantis NJ, Cavacini LA, Sullivan-Bolyai J, Hu LT, Embers ME, Klempner MS, Wang Y (2021) Blocking Borrelia burgdorferi transmission from infected ticks to nonhuman primates with a human monoclonal antibody. J Clin Invest 131(11):e144843. https:\/\/doi.org\/10.1172\/jci144843","DOI":"10.1172\/jci144843"},{"issue":"1","key":"11989_CR84","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/ja.2013.100","volume":"67","author":"EW Sewell","year":"2014","unstructured":"Sewell EW, Brown ED (2014) Taking aim at wall teichoic acid synthesis: new biology and new leads for antibiotics. J Antibiot (tokyo) 67(1):43\u201351. https:\/\/doi.org\/10.1038\/ja.2013.100","journal-title":"J Antibiot (tokyo)"},{"issue":"2","key":"11989_CR85","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s12275-015-4519-4","volume":"53","author":"R Shokri","year":"2015","unstructured":"Shokri R, Salouti M, Zanjani RS (2015) Anti protein A antibody-gold nanorods conjugate: a targeting agent for selective killing of methicillin resistant Staphylococcus aureus using photothermal therapy method. J Microbiol 53(2):116\u2013121. https:\/\/doi.org\/10.1007\/s12275-015-4519-4","journal-title":"J Microbiol"},{"issue":"9","key":"11989_CR86","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1172\/JCI42748","volume":"120","author":"D Skurnik","year":"2010","unstructured":"Skurnik D, Merighi M, Grout M, Gadjeva M, Maira-Litran T, Ericsson M, Goldmann DA, Huang SS, Datta R, Lee JC, Pier GB (2010) Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice. J Clin Invest 120(9):3220\u20133233. https:\/\/doi.org\/10.1172\/JCI42748","journal-title":"J Clin Invest"},{"issue":"9","key":"11989_CR87","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/cid\/cis624","volume":"55","author":"D Skurnik","year":"2012","unstructured":"Skurnik D, Kropec A, Roux D, Theilacker C, Huebner J, Pier GB (2012) Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy. Clin Infect Dis 55(9):1188\u20131197. https:\/\/doi.org\/10.1093\/cid\/cis624","journal-title":"Clin Infect Dis"},{"issue":"7","key":"11989_CR88","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00108-017-0268-2","volume":"58","author":"P Solbach","year":"2017","unstructured":"Solbach P, Dersch P, Bachmann O (2017) Individualized treatment strategies for Clostridium difficile infections. Internist (berl) 58(7):675\u2013681. https:\/\/doi.org\/10.1007\/s00108-017-0268-2","journal-title":"Internist (berl)"},{"issue":"3","key":"11989_CR89","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jaip.2019.01.024","volume":"7","author":"RU Sorensen","year":"2019","unstructured":"Sorensen RU, Edgar D (2019) Specific antibody deficiencies in clinical practice. J Allergy Clin Immunol Pract 7(3):801\u2013808. https:\/\/doi.org\/10.1016\/j.jaip.2019.01.024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"11989_CR90","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/nchem.2635","volume":"8","author":"LR Staben","year":"2016","unstructured":"Staben LR, Koenig SG, Lehar S, Vandlen R, Zhang D, Chuh J, Yu S-F, Ng C, Guo J, Liu Y, Fourie-O\u2019Donohue A, Go M, Linghu X, Segraves NL, Wang T, Chen J, Wei B, Phillips GDL, Xu K, Kozak KR, Mariathasan S, Flygare JA, Pillow TH (2016) Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody-drug conjugates. Nat Chem 8(12):1112\u20131119.\u00a0https:\/\/doi.org\/10.1038\/nchem.2635","journal-title":"Nat Chem"},{"key":"11989_CR91","doi-asserted-by":"publisher","unstructured":"Storek KM, Vij R, Sun D, Smith PA, Koerber JT, Rutherford ST (2019) The Escherichia coli \u03b2-barrel assembly machinery is sensitized to perturbations under high membrane fluidity. J Bacteriol 201(1):e00517\u201318. https:\/\/doi.org\/10.1128\/jb.00517-18","DOI":"10.1128\/jb.00517-18"},{"key":"11989_CR92","doi-asserted-by":"publisher","unstructured":"Sundin C, Saleeb M, Spjut S, Qin L, Elofsson M (2021) Identification of small molecules blocking the Pseudomonas aeruginosa type III secretion system protein PcrV. Biomolecules 11(1):55. https:\/\/doi.org\/10.3390\/biom11010055","DOI":"10.3390\/biom11010055"},{"issue":"7","key":"11989_CR93","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1080\/21505594.2017.1279778","volume":"8","author":"V Szij\u00e1rt\u00f3","year":"2017","unstructured":"Szij\u00e1rt\u00f3 V, Guachalla LM, Hartl K, Varga C, Badarau A, Mirkina I, Visram ZC, Stulik L, Power CA, Nagy E, Nagy G (2017) Endotoxin neutralization by an O-antigen specific monoclonal antibody: a potential novel therapeutic approach against Klebsiella pneumoniae ST258. Virulence 8(7):1203\u20131215. https:\/\/doi.org\/10.1080\/21505594.2017.1279778","journal-title":"Virulence"},{"issue":"19","key":"11989_CR94","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1016\/j.vaccine.2009.02.051","volume":"27","author":"T Takahashi","year":"2009","unstructured":"Takahashi T, Joshi SG, Al-Saleem F, Ancharski D, Singh A, Nasser Z, Simpson LL (2009) Localization of the sites and characterization of the mechanisms by which anti-light chain antibodies neutralize the actions of the botulinum holotoxin. Vaccine 27(19):2616\u20132624. https:\/\/doi.org\/10.1016\/j.vaccine.2009.02.051","journal-title":"Vaccine"},{"issue":"4","key":"11989_CR95","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.vaccine.2014.11.051","volume":"33","author":"V Thammavongsa","year":"2015","unstructured":"Thammavongsa V, Rauch S, Kim HK, Missiakas DM, Schneewind O (2015) Protein A-neutralizing monoclonal antibody protects neonatal mice against Staphylococcus aureus. Vaccine 33(4):523\u2013526. https:\/\/doi.org\/10.1016\/j.vaccine.2014.11.051","journal-title":"Vaccine"},{"key":"11989_CR96","doi-asserted-by":"publisher","unstructured":"Tim R, Valeria S, Jolanta L, M GL, Katarina S, Katharina H, Lukas S, Simone K, Felix L, Mohammed A-S, Jutta S-B, Moritz vF, Gereon G, Peter H, Sabrina K, Klaus H, Eszter N, Gabor N, Hedda W (2018) Cross-specificity of protective human antibodies against Klebsiella pneumoniae LPS O-antigen. Nat Immunol 19(6):617\u2013624. https:\/\/doi.org\/10.1038\/s41590-018-0106-2","DOI":"10.1038\/s41590-018-0106-2"},{"key":"11989_CR97","doi-asserted-by":"publisher","unstructured":"Tkaczyk C, Semenova E, Sih YY, Rosenthal K, Oganesyan V, Warrener P, Stover CK, Sellman BR (2018) Alanine scanning mutagenesis of the MEDI4893 (Suvratoxumab) epitope reduces alpha toxin lytic activity in vitro and Staphylococcus aureus fitness in infection models. Antimicrobial Agents and Chemotherapy 62(11):e01033\u201318. https:\/\/doi.org\/10.1128\/aac.01033-18","DOI":"10.1128\/aac.01033-18"},{"issue":"4","key":"11989_CR98","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2116\/analsci.17R003","volume":"34","author":"K Todoroki","year":"2018","unstructured":"Todoroki K, Yamada T, Mizuno H, Toyo\u2019oka T (2018) Current mass spectrometric tools for the bioanalyses of therapeutic monoclonal antibodies and antibody-drug conjugates. Anal Sci 34(4):397\u2013406. https:\/\/doi.org\/10.2116\/analsci.17R003","journal-title":"Anal Sci"},{"key":"11989_CR99","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1146\/annurev.immunol.20.103001.114744","volume":"20","author":"DM Underhill","year":"2002","unstructured":"Underhill DM, Ozinsky A (2002) Phagocytosis of microbes: complexity in action. Annu Rev Immunol 20:825\u2013852. https:\/\/doi.org\/10.1146\/annurev.immunol.20.103001.114744","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"11989_CR100","doi-asserted-by":"publisher","first-page":"e1007056","DOI":"10.1371\/journal.ppat.1007056","volume":"14","author":"P Uppuluri","year":"2018","unstructured":"Uppuluri P, Lin L, Alqarihi A, Luo G, Youssef EG, Alkhazraji S, Yount NY, Ibrahim BA, Bolaris MA, Edwards JE Jr, Swidergall M, Filler SG, Yeaman MR, Ibrahim AS (2018) The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection. PLoS Pathog 14(5):e1007056. https:\/\/doi.org\/10.1371\/journal.ppat.1007056","journal-title":"PLoS Pathog"},{"key":"11989_CR101","doi-asserted-by":"publisher","unstructured":"Varshney AK, Kuzmicheva GA, Lin J, Sunley KM, Bowling RA, Jr., Kwan T-Y, Mays HR, Rambhadran A, Zhang Y, Martin RL, Cavalier MC, Simard J, Shivaswamy S (2018) A natural human monoclonal antibody targeting Staphylococcus Protein A protects against Staphylococcus aureus bacteremia. Plos One 13(1):e0190537. https:\/\/doi.org\/10.1371\/journal.pone.0190537","DOI":"10.1371\/journal.pone.0190537"},{"key":"11989_CR102","doi-asserted-by":"publisher","unstructured":"Vij R, Lin ZH, Chiang N, Vernes JM, Storek KM, Park S, Chan J, Meng YG, Comps-Agrar L, Luan P, Lee S, Schneider K, Bevers J, Zilberleyb I, Tam C, Koth CM, Xu M, Gill A, Auerbach MR, Smith PA, Rutherford ST, Nakamura G, Seshasayee D, Payandeh J, Koerber JT (2018) A targeted boost-and-sort immunization strategy using Escherichia coli BamA identifies rare growth inhibitory antibodies. Sci Rep 8(1):7136. https:\/\/doi.org\/10.1038\/s41598-018-25609-z","DOI":"10.1038\/s41598-018-25609-z"},{"key":"11989_CR103","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.coche.2018.01.007","volume":"19","author":"EK Wagner","year":"2018","unstructured":"Wagner EK, Maynard JA (2018) Engineering therapeutic antibodies to combat infectious diseases. Curr Opin Chem Eng 19:131\u2013141. https:\/\/doi.org\/10.1016\/j.coche.2018.01.007","journal-title":"Curr Opin Chem Eng"},{"issue":"11","key":"11989_CR104","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1093\/infdis\/jiw021","volume":"213","author":"Q Wang","year":"2016","unstructured":"Wang Q, Chang CS, Pennini M, Pelletier M, Rajan S, Zha J, Chen Y, Cvitkovic R, Sadowska A, Heidbrink Thompson J, Yu Lin H, Barnes A, Rickert K, Wilson S, Stover CK, Dall\u2019Acqua WF, Chowdhury PS, Xiao X (2016) Target-agnostic identification of functional monoclonal antibodies against Klebsiella pneumoniae multimeric MrkA fimbrial subunit. J Infect Dis 213(11):1800\u20131808. https:\/\/doi.org\/10.1093\/infdis\/jiw021","journal-title":"J Infect Dis"},{"issue":"2","key":"11989_CR105","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/infdis\/jiw151","volume":"214","author":"Y Wang","year":"2016","unstructured":"Wang Y, Kern A, Boatright NK, Schiller ZA, Sadowski A, Ejemel M, Souders CA, Reimann KA, Hu L, Thomas WD Jr, Klempner MS (2016) Pre-exposure prophylaxis with OspA-specific human monoclonal antibodies protects mice against tick transmission of lyme disease spirochetes. J Infect Dis 214(2):205\u2013211. https:\/\/doi.org\/10.1093\/infdis\/jiw151","journal-title":"J Infect Dis"},{"issue":"1","key":"11989_CR106","doi-asserted-by":"publisher","first-page":"e0170529","DOI":"10.1371\/journal.pone.0170529","volume":"12","author":"Q Wang","year":"2017","unstructured":"Wang Q, Chen Y, Cvitkovic R, Pennini ME, Chang CS, Pelletier M, Bonnell J, Koksal AC, Wu H, Dall\u2019Acqua WF, Stover CK, Xiao X (2017) Anti-MrkA monoclonal antibodies reveal distinct structural and antigenic features of MrkA. PLoS ONE 12(1):e0170529. https:\/\/doi.org\/10.1371\/journal.pone.0170529","journal-title":"PLoS ONE"},{"issue":"7","key":"11989_CR107","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1080\/19420862.2018.1494478","volume":"10","author":"SX Wang-Lin","year":"2018","unstructured":"Wang-Lin SX, Zhou CG, Kamath AV, Hong K, Koppada N, Saad OM, Carrasco-Triguero M, Khojasteh C, Deng R (2018) Minimal physiologically-based pharmacokinetic modeling of DSTA4637A, A novel THIOMAB (TM) antibody antibiotic conjugate against Staphylococcus aureus, in a mouse model. MAbs 10(7):1131\u20131143. https:\/\/doi.org\/10.1080\/19420862.2018.1494478","journal-title":"MAbs"},{"issue":"8","key":"11989_CR108","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1128\/AAC.02643-14","volume":"58","author":"P Warrener","year":"2014","unstructured":"Warrener P, Varkey R, Bonnell JC, DiGiandomenico A, Camara M, Cook K, Peng L, Zha J, Chowdury P, Sellman B, Stover CK (2014) A novel anti-PcrV antibody providing enhanced protection against Pseudomonas aeruginosa in multiple animal infection models. Antimicrob Agents Chemother 58(8):4384\u20134391. https:\/\/doi.org\/10.1128\/AAC.02643-14","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"11989_CR109","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2302\/kjm.60.37","volume":"60","author":"T Yamada","year":"2011","unstructured":"Yamada T (2011) Therapeutic monoclonal antibodies. Keio J Med 60(2):37\u201346. https:\/\/doi.org\/10.2302\/kjm.60.37","journal-title":"Keio J Med"},{"issue":"10","key":"11989_CR110","doi-asserted-by":"publisher","first-page":"5796","DOI":"10.1128\/AAC.01102-16","volume":"60","author":"BJ Yamamoto","year":"2016","unstructured":"Yamamoto BJ, Shadiack AM, Carpenter S, Sanford D, Henning LN, Gonzales N, O\u2019Connor E, Casey LS, Serbina NV (2016) Obiltoxaximab prevents disseminated Bacillus anthracis infection and improves survival during pre- and postexposure prophylaxis in animal models of inhalational anthrax. Antimicrob Agents Chemother 60(10):5796\u20135805. https:\/\/doi.org\/10.1128\/AAC.01102-16","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"11989_CR111","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.1128\/AAC.00972-16","volume":"60","author":"BJ Yamamoto","year":"2016","unstructured":"Yamamoto BJ, Shadiack AM, Carpenter S, Sanford D, Henning LN, O\u2019Connor E, Gonzales N, Mondick J, French J, Stark GV, Fisher AC, Casey LS, Serbina NV (2016) Efficacy projection of obiltoxaximab for treatment of inhalational anthrax across a range of disease severity. Antimicrob Agents Chemother 60(10):5787\u20135795. https:\/\/doi.org\/10.1128\/AAC.00972-16","journal-title":"Antimicrob Agents Chemother"},{"key":"11989_CR112","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fcimb.2020.00145","volume":"10","author":"X Yang","year":"2020","unstructured":"Yang X, He Z, Zhang G, Lu J, Zhang H, Ren H, Tian Y, Yang H, Chen C, Li L, Fu Y, Allain JP, Li C, Wang W (2020) Evaluation of reactivity of monoclonal antibodies against Omp25 of Brucella spp. Front Cell Infect Microbiol 10:145. https:\/\/doi.org\/10.3389\/fcimb.2020.00145","journal-title":"Front Cell Infect Microbiol"},{"key":"11989_CR113","doi-asserted-by":"publisher","unstructured":"Yang Y, Qian M, Yi S, Liu S, Li B, Yu R, Guo Q, Zhang X, Yu C, Li J, Xu J, Chen W (2016) Monoclonal antibody targeting Staphylococcus aureus surface Protein A (SasA) protect against Staphylococcus aureus sepsis and peritonitis in mice. Plos One 11(2):e0149460. https:\/\/doi.org\/10.1371\/journal.pone.0149460","DOI":"10.1371\/journal.pone.0149460"},{"key":"11989_CR114","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fimmu.2020.00076","volume":"11","author":"EG Youssef","year":"2020","unstructured":"Youssef EG, Zhang L, Alkhazraji S, Gebremariam T, Singh S, Yount NY, Yeaman MR, Uppuluri P, Ibrahim AS (2020) Monoclonal IgM antibodies targeting Candida albicans Hyr1 provide cross-kingdom protection against gram-negative bacteria. Front Immunol 11:76. https:\/\/doi.org\/10.3389\/fimmu.2020.00076","journal-title":"Front Immunol"},{"issue":"6","key":"11989_CR115","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1167\/iovs.18-23795","volume":"59","author":"TS Zaidi","year":"2018","unstructured":"Zaidi TS, Zaidi T, Pier GB (2018) Antibodies to conserved surface polysaccharides protect mice against bacterial conjunctivitis. Invest Ophthalmol vis Sci 59(6):2512\u20132519. https:\/\/doi.org\/10.1167\/iovs.18-23795","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"10","key":"11989_CR116","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/infdis\/jiaa602","volume":"223","author":"H Zeng","year":"2021","unstructured":"Zeng H, Zhang J, Song X, Zeng J, Yuan Y, Chen Z, Xu L, Gou Q, Yang F, Zeng N, Zhang Y, Peng L, Zhao L, Zhu J, Liu Y, Luo P, Zou Q, Zhao Z (2021) An immunodominant epitope-specific monoclonal antibody cocktail improves survival in a mouse model of Staphylococcus aureus bacteremia. J Infect Dis 223(10):1743\u20131752. https:\/\/doi.org\/10.1093\/infdis\/jiaa602","journal-title":"J Infect Dis"},{"key":"11989_CR117","doi-asserted-by":"publisher","unstructured":"Zeng H, Yang F, Feng Q, Zhang J, Gu J, Jing H, Cai C, Xu L, Yang X, Xia X, Zeng N, Fan S, Zou Q (2020) Rapid and broad immune efficacy of a recombinant five-antigen vaccine against Staphylococcus aureus infection in animal models. Vaccines (Basel) 8(1):134. https:\/\/doi.org\/10.3390\/vaccines8010134","DOI":"10.3390\/vaccines8010134"},{"issue":"8","key":"11989_CR118","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1080\/19420862.2016.1229722","volume":"8","author":"C Zhou","year":"2016","unstructured":"Zhou C, Lehar S, Gutierrez J, Rosenberger CM, Ljumanovic N, Dinoso J, Koppada N, Hong K, Baruch A, Carrasco-Triguero M, Saad O, Mariathasan S, Kamath AV (2016) Pharmacokinetics and pharmacodynamics of DSTA4637A: a novel THIOMAB antibody antibiotic conjugate against Staphylococcus aureus in mice. MAbs 8(8):1612\u20131619. https:\/\/doi.org\/10.1080\/19420862.2016.1229722","journal-title":"MAbs"},{"issue":"10","key":"11989_CR119","doi-asserted-by":"publisher","first-page":"e0224096","DOI":"10.1371\/journal.pone.0224096","volume":"14","author":"C Zhou","year":"2019","unstructured":"Zhou C, Cai H, Baruch A, Lewin-Koh N, Yang M, Guo F, Xu D, Deng R, Hazenbos W, Kamath AV (2019) Sustained activity of novel THIOMAB antibody-antibiotic conjugate against Staphylococcus aureus in a mouse model: longitudinal pharmacodynamic assessment by bioluminescence imaging. PLoS ONE 14(10):e0224096\u2013e0224096. https:\/\/doi.org\/10.1371\/journal.pone.0224096","journal-title":"PLoS ONE"},{"issue":"3","key":"11989_CR120","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jmii.2019.08.019","volume":"54","author":"TT Zhou","year":"2021","unstructured":"Zhou TT, Yue Y, Zheng F, Liang XD, Cao QX, Wang YW, Zhu J (2021) Monoclonal antibody against l-lectin module of SraP blocks adhesion and protects mice against Staphylococcus aureus challenge. J Microbiol Immunol Infect 54(3):420\u2013428. https:\/\/doi.org\/10.1016\/j.jmii.2019.08.019","journal-title":"J Microbiol Immunol Infect"},{"key":"11989_CR121","doi-asserted-by":"publisher","unstructured":"Zurawski DV, McLendon MK (2020) Monoclonal antibodies as an antibacterial approach against bacterial pathogens. Antibiotics (Basel) 9(4):155. https:\/\/doi.org\/10.3390\/antibiotics9040155","DOI":"10.3390\/antibiotics9040155"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-022-11989-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-022-11989-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-022-11989-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T15:51:30Z","timestamp":1684857090000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-022-11989-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":121,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["11989"],"URL":"https:\/\/doi.org\/10.1007\/s00253-022-11989-w","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"26 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any new studies with human participants or animals performed by any authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}